Dr. Hugo CeulemansAssociate Scientific Director, Computational Systems Biology, Janssen, Janssen Pharmaceutical Companies
Hugo holds the degrees of M.D., M.Sc. in Bioinformatics and Ph.D. in Molecular Biology from the University of Leuven, and did postdoctoral fellowships in molecular and computational phosphatase biology at the University of Leuven and in structural bioinformatics at the European Molecular Biology Laboratories in Heidelberg. He joined Janssen in 2008 as a computational biologist supporting the Infectious Diseases and Vaccines franchise with omics analysis capabilities and models to predict patient responses to antivirals based on the DNA sequence of viral strains and drug characteristics. Over the years, his responsibilities extended to cover additional computational approaches and an increasing number of disease franchises. In 2012, these activities were consolidated in a new Computational Systems Biology unit, which now offers capabilities in the analysis and integration of sets of chemical, biochemical, omics, phenotypic and clinical data and their formalization in predictive quantitative models, to all Janssen pharmaceutical companies. The unit is also responsible for many of the business applications of high-performance computation.